+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Medical therapy with mebendazole in hydatid cyst disease. A follow-up of 40 cases

Medical therapy with mebendazole in hydatid cyst disease. A follow-up of 40 cases

Minerva Medica 80(3): 205-214

Mebendazole (50-60 mg/kg/day in 7-8 divided doses after fatty rich meals for at least 6 months) was given to 44 patients with cystic hydatid disease of the liver and other organs, about 1/3 having suffered from recurrences, even multiple, before beginning the pharmacological treatment. Fifteen patients underwent operation after a course of mebendazole, and macroscopic and histological degeneration of hydatid cysts was always documented; sixteen subjects were not operated due to their severe general and/or local conditions but ultrasound, radiologic (CT) and clinical evidence of cyst regression was obtained, and was closely comparable to that in the aforementioned group. Some of the patients (13) began the treatment only after conservative surgery. The mean real follow-up available at the moment is for 40 subjects because 2 patients did not show adequate compliance for the drug and in 2 additional cases it was withdrawn because of an increase in serum transaminases. The rate of recurrence was 7.5% and occurred in high-risk patients (multiple, bone, lung locations) who had, however, an additional and longer course of mebendazole with good results. The detachment of membranes and the increase of internal echoes, observed by means of ultrasonography, which was successfully applied to liver and soft tissue sites as well as the decrease in blood eosinophils when elevated before therapy, were observed to be the most sensitive indicators of early success in the medical treatment for hydatid disease, as far as the viability of parasite cysts was concerned.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 040668812

Download citation: RISBibTeXText

PMID: 2654757

Related references

Chemotherapy of human hydatid disease with mebendazole. Follow-up of 16 cases. Acta Gastro-Enterologica Belgica 43(1-3): 48-65, 1980

Abdominal hydatid disease: follow-up of mebendazole therapy by CT and ultrasonography. International Surgery 71(1): 22-26, 1986

Therapy of human hydatid disease with mebendazole: first attempts of correlating plasma and cyst levels with therapeutic results. Giornale di Malattie Infettive e Parassitarie 37(1/3): 88-90, 1985

Treatment of hydatid disease with high oral doses of mebendazole. Long-term follow-up of plasma mebendazole levels and drug interactions. European Journal of Clinical Pharmacology 31(4): 443-448, 1986

Experimental treatment of alveolar hydatid disease x. the effect of mebendazole bcg or mebendazole levamisole combinations on the course of hydatid disease simulated in mice. Meditsinskaya Parazitologiya i Parazitarnye Bolezni (6): 27-31, 1986

"Low dose mebendazole therapy in pulmonary hydatid cyst". Journal of the Association of Physicians of India 36(9): 571-572, 1988

Low dose mebendazole therapy in pulmonary hydatid cyst. Journal of the Association of Physicians of India 38(7): 519-520, 1990

Serum and cyst concentrations of mebendazole and flubendazole in hydatid disease. British Medical Journal 285(6336): 175-175, 1982

Cyst and host tissue concentrations of mebendazole in patients undergoing surgery for hydatid disease. Medical Journal of Australia 2(8): 383-384, 1983

In vivo efficacy of mebendazole in containment of larval cyst mass in early stages of hydatid disease due to Echinococcus granulosus. Transactions of the Royal Society of Tropical Medicine and Hygiene 81(6): 965-966, 1987

Treatment of hepatic hydatid disease with mebendazole: report of 16 cases. East African Medical Journal 58(8): 608-610, 1981

Albendazole therapy of hydatid disease: 2-year follow-up of 40 cases. Annals of Tropical Medicine and Parasitology 87(3): 241-246, 1993

Mebendazole therapy in extensive hydatid disease. Indian Journal of Gastroenterology 11(1): 40, 1992

Leukopenia associated with mebendazole therapy of hydatid disease. American Journal of Tropical Medicine and Hygiene 29(6): 1356-1358, 1980

Agranulocytosis, a complication of mebendazole therapy for hydatid disease. Meditsinskaya Parazitologiya i Parazitarnye Bolezni ( 5-6): 9-11, 1992